Echevarria F, Caputo M, Camp D, Reddy S, Achenbach C
PLoS One. 2024; 19(8):e0302338.
PMID: 39102410
PMC: 11299831.
DOI: 10.1371/journal.pone.0302338.
Moreno-Echevarria F, Caputo M, Camp D, Reddy S, Achenbach C
medRxiv. 2024; .
PMID: 38633797
PMC: 11023664.
DOI: 10.1101/2024.04.03.24305293.
Aryal K, Mowbray F, Miroshnychenko A, Strum R, Dash D, Hillmer M
BMC Med Res Methodol. 2024; 24(1):77.
PMID: 38539074
PMC: 10976701.
DOI: 10.1186/s12874-024-02189-3.
Hashan M, Smoll N, Chapman G, King C, Walker J, Kirk M
BMJ Open. 2024; 14(3):e073555.
PMID: 38485480
PMC: 10941149.
DOI: 10.1136/bmjopen-2023-073555.
Moxley T, Johnson-Leung J, Seamon E, Williams C, Ridenhour B
PLoS One. 2024; 19(1):e0297065.
PMID: 38277346
PMC: 10817220.
DOI: 10.1371/journal.pone.0297065.
Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination.
Walmsley S, Nabipoor M, Lovblom L, Ravindran R, Colwill K, Mcgeer A
Vaccines (Basel). 2024; 12(1).
PMID: 38250849
PMC: 10820583.
DOI: 10.3390/vaccines12010036.
Disparities in COVID-19 Vaccination Status Among Long-Term Care Facility Residents - United States, October 31, 2022-May 7, 2023.
Haanschoten E, Dubendris H, Reses H, Barbre K, Meng L, Benin A
MMWR Morb Mortal Wkly Rep. 2023; 72(40):1095-1098.
PMID: 37796756
PMC: 10564329.
DOI: 10.15585/mmwr.mm7240a4.
Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse.
Hsu C, Weiner D, Manley H, Li N, Miskulin D, Harford A
Kidney Med. 2023; 5(11):100718.
PMID: 37786901
PMC: 10542005.
DOI: 10.1016/j.xkme.2023.100718.
Impact of a COVID-19 Outbreak in an Elderly Care Home after Primary Vaccination.
Mauriz E, Fernandez-Vazquez J, Diez-Flecha C, Reguero-Celada S, Fernandez-Villa T, Fernandez-Somoano A
Vaccines (Basel). 2023; 11(8).
PMID: 37631950
PMC: 10459698.
DOI: 10.3390/vaccines11081382.
A Meta-Analysis To Ascertain the Effectiveness of COVID-19 Vaccines on Clinical Outcomes in Patients With COVID-19 Infection in North America.
Ikeokwu A, Adeniran O, Marwizi F, Kolade-Ernest O, Solomon R, Ogedengbe W
Cureus. 2023; 15(6):e41053.
PMID: 37519527
PMC: 10374409.
DOI: 10.7759/cureus.41053.
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers.
Nugent C, Abul Y, White E, Shehadeh F, Kaczynski M, Felix L
Vaccine. 2023; 41(22):3403-3409.
PMID: 37117056
PMC: 10123357.
DOI: 10.1016/j.vaccine.2023.04.034.
Resident Factors Associated With Breakthrough SARS-CoV-2 Infections.
Montoya A, Wen K, Travers J, Rivera-Hernandez M, White E, Mor V
J Am Med Dir Assoc. 2023; 24(6):901-905.
PMID: 36965506
PMC: 9977610.
DOI: 10.1016/j.jamda.2023.02.102.
Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes.
McGarry B, Gandhi A, Barnett M
N Engl J Med. 2023; 388(12):1101-1110.
PMID: 36947467
PMC: 10052223.
DOI: 10.1056/NEJMoa2210063.
The Role of Individual-Level Socioeconomic Status on Nursing Home Placement Accounting for Neighborhood Characteristics.
Ryu E, Wi C, Wheeler P, King K, Carlson R, Juhn Y
J Am Med Dir Assoc. 2023; 24(7):1048-1053.e2.
PMID: 36841262
PMC: 10962058.
DOI: 10.1016/j.jamda.2023.01.016.
Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity.
Bao P, Gong J, Mu M, Que Y, Hu P, Luo J
Chin Med J (Engl). 2023; 136(13):1627-1629.
PMID: 36806245
PMC: 10325752.
DOI: 10.1097/CM9.0000000000002270.
Epidemiology and Clinical Presentation of COVID-19 in Older Adults.
Abul Y, Leeder C, Gravenstein S
Infect Dis Clin North Am. 2023; 37(1):1-26.
PMID: 36805007
PMC: 9633621.
DOI: 10.1016/j.idc.2022.11.001.
Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults.
Semelka C, DeWitt M, Blevins M, Holbrook B, Sanders J, Alexander-Miller M
Immun Ageing. 2023; 20(1):4.
PMID: 36650551
PMC: 9843107.
DOI: 10.1186/s12979-023-00327-x.
Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster.
McConeghy K, Bardenheier B, Huang A, White E, Feifer R, Blackman C
JAMA Netw Open. 2022; 5(12):e2245417.
PMID: 36477482
PMC: 9856563.
DOI: 10.1001/jamanetworkopen.2022.45417.
Risk factors for severe Covid-19 breakthrough infections: an observational longitudinal study.
Ben Fredj S, Ghammem R, Zammit N, Maatouk A, Haddad N, Haddad N
BMC Infect Dis. 2022; 22(1):894.
PMID: 36443699
PMC: 9706846.
DOI: 10.1186/s12879-022-07859-5.
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?.
Pons S, Uhel F, Frapy E, Sereme Y, Zafrani L, Aschard H
Stem Cell Rev Rep. 2022; 19(3):585-600.
PMID: 36422774
PMC: 9685122.
DOI: 10.1007/s12015-022-10477-y.
